| Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy C Lanaro, CF Franco-Penteado, DM Albuqueque, STO Saad, N Conran, ... Journal of Leucocyte Biology 85 (2), 235-242, 2009 | 239 | 2009 |
| Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms. Part II: Furoxan derivatives JL Dos Santos, C Lanaro, RC Chelucci, S Gambero, PL Bosquesi, ... Journal of medicinal chemistry 55 (17), 7583-7592, 2012 | 67 | 2012 |
| Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms JL Dos Santos, C Lanaro, LM Lima, S Gambero, CF Franco-Penteado, ... Journal of medicinal chemistry 54 (16), 5811-5819, 2011 | 54 | 2011 |
| Association of nitric oxide synthase and matrix metalloprotease single nucleotide polymorphisms with preeclampsia and its complications DP Leonardo, DM Albuquerque, C Lanaro, LC Baptista, JG Cecatti, ... PloS one 10 (8), e0136693, 2015 | 44 | 2015 |
| Erythropoiesis‐driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth … KY Fertrin, C Lanaro, CF Franco‐Penteado, DM de Albuquerque, ... American journal of hematology 89 (4), 385-390, 2014 | 35 | 2014 |
| High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia IF Domingos, DA Pereira-Martins, MJVC Sobreira, RTD Oliveira, ... Annals of Hematology 99, 947-953, 2020 | 34 | 2020 |
| Oxidative stress associated with middle aging leads to sympathetic hyperactivity and downregulation of soluble guanylyl cyclase in corpus cavernosum FH Silva, C Lanaro, LO Leiria, RL Rodrigues, AP Davel, MA Claudino, ... American Journal of Physiology-Heart and Circulatory Physiology 307 (10 …, 2014 | 34 | 2014 |
| Increased adhesive and inflammatory properties in blood outgrowth endothelial cells from sickle cell anemia patients TM Sakamoto, C Lanaro, MC Ozelo, VT Garrido, ST Olalla-Saad, ... Microvascular research 90, 173-179, 2013 | 34 | 2013 |
| High expression of the cGMP‐specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophils CB Almeida, F Traina, C Lanaro, AA Canalli, STO Saad, FF Costa, ... British journal of haematology 142 (5), 836-844, 2008 | 34 | 2008 |
| Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients OS Olatunya, C Lanaro, AL Longhini, CFF Penteado, KY Fertrin, ... Annals of hematology 98, 2507-2521, 2019 | 31 | 2019 |
| Inhibition of caspase‐dependent spontaneous apoptosis via a cAMP‐protein kinase A dependent pathway in neutrophils from sickle cell disease patients N Conran, CB Almeida, C Lanaro, RP Ferreira, F Traina, STO Saad, ... British journal of haematology 139 (1), 148-158, 2007 | 27 | 2007 |
| Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia KS Romanello, KKL Teixeira, JPMO Silva, ST Nagamatsu, MAC Bezerra, ... PLoS One 13 (12), e0208316, 2018 | 24 | 2018 |
| Use of Phthalimide and/or Sulphonamide Derivatives in the Treatment of Diseases Which Require Reducing the TNF-alpha Levels and an Exogenous Source of Nitric Oxide, Phthalimide … JL Dos Santos, CC Man, LM Lima, FF Costa, C Lanaro US Patent App. 12/747,589, 2010 | 22 | 2010 |
| Global gene expression reveals a set of new genes involved in the modification of cells during erythroid differentiation AF Da Cunha, AF Brugnerotto, AS Duarte, C Lanaro, GGL Costa, ... Cell proliferation 43 (3), 297-309, 2010 | 21 | 2010 |
| Expression of new red cell–related genes in erythroid differentiation T De Andrade, L Moreira, A Duarte, C Lanaro, D De Albuquerque, S Saad, ... Biochemical genetics 48, 164-171, 2010 | 20 | 2010 |
| Abnormal expression of inflammatory genes in placentas of women with sickle cell anemia and sickle hemoglobin C disease LC Baptista, ML Costa, R Ferreira, DM Albuquerque, C Lanaro, KY Fertrin, ... Annals of hematology 95, 1859-1867, 2016 | 19 | 2016 |
| Advances in sickle cell disease treatment: from drug discovery until the patient monitoring J Leandro dos Santos, C Lanaro, C Man Chin Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2011 | 19 | 2011 |
| Gene expression profiles of erythroid precursors characterise several mechanisms of the action of hydroxycarbamide in sickle cell anaemia F Chagas Costa, A Ferreira da Cunha, A Fattori, T De Sousa Peres, ... British journal of haematology 136 (2), 333-342, 2007 | 19 | 2007 |
| Synthesis and evaluation of resveratrol derivatives as fetal hemoglobin inducers PL Bosquesi, ACB Melchior, AR Pavan, C Lanaro, CM de Souza, ... Bioorganic chemistry 100, 103948, 2020 | 18 | 2020 |
| PIP4KIIA and β‐globin: transcripts differentially expressed in reticulocytes and associated with high levels of Hb H in two siblings with Hb H disease MRSC Wenning, MP Mello, TG Andrade, C Lanaro, DM Albuquerque, ... European journal of haematology 83 (5), 490-493, 2009 | 14 | 2009 |
Fernando Ferreira CostaUNICAMP,State university of Campinas,University of CampinasDirección de correo verificada de unicamp.br
